Author:
Peštálová Andrea,Hořavová Hana,Gajdziok Jan
Abstract
Inhalation administration of dry powder particles is a common application route to achieve local and systemic drug effects. For pulmonary diseases, the deposition of drugs at the site of action is desirable. Thus, the parameters of the inhaled particles,
Reference22 articles.
1. 1. Hořavová H., Gajdziok J., Vetchý D. Typy a příprava lipozomálních přípravků pro plicní podání. Chem. Listy. 2020; 114, 322-328.
2. 2. Edwards D., A., Ben-Jebria A., Langer R. Recent advances in pulmonary drug delivery using large, porous inhaled particles. J. Appl. Physiol. 1998; 85, 379-385.
3. 3. Liang Z., Ni R., Zhou J., Mao S. Recent advances in controlled pulmonary drug delivery. Drug Discov. Today 2015; 20, 380-389.
4. 4. Karas J., Vetchý D., Gajdziok J. Dry powder particles for pulmonary application. Chem. Listy 2022; 116, 28-34.
5. 5. Gharse S., Fiegel J. Large porous hollow particles: lightweight champions of pulmonary drug delivery. Curr. Pharm. Des. 2016; 22, 2463-2469.